| Value | ₹11.58 Cr |
|---|
BSE filing, NSE: INDRANIB. Summary written from the filing by ALFA Finder's alert engine.
Indrayani Biotech Ltd: key numbers
- Share price
- ₹7.65
- Market cap
- ₹41.06 Cr
- Revenue (annual)
- ₹137.8 Cr
- Net profit (annual)
- ₹2.16 Cr
- P/E (TTM)
- 19.6×Sector 26.8×
- Promoter holding
- 32.92%-0.34% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indrayani Biotech Ltd
All →Indrayani Biotech Capital Structure Change
Indrayani Biotech's committee allotted 83,64,036 partly paid rights shares at Rs.15 each, worth about Rs.12.55 crore. Application money of Rs.3.75 per share has been received.
- Value
- ₹12.55 Cr
Indrayani Biotech Board Meeting Date
Indrayani Biotech Ltd has scheduled a Board meeting for November 06, 2026. The meeting will primarily consider the notice for the company's 34th Annual General Meeting.
Indrayani Biotech Board Meeting Outcome
Indrayani Biotech appointed Ms. N. S. Poornima as Secretarial Auditor for FY 2025-26 to fill a casual vacancy. Company Secretary C.S. Shanmuga Sundar's resignation took effect on 2 November 2026.
Indrayani Biotech Legal & Regulatory
Indrayani Biotech received a tax recovery notice for outstanding demands totaling ₹1.17 Crore for various assessment years, for which the company has filed responses.
- Value
- ₹1.17 Cr
Indrayani Biotech Management Change
Independent Director Mr. K.S. Vaidyanathan has resigned from the Board of Indrayani Biotech Limited, effective October 13, 2026, due to personal reasons.
Indrayani Biotech Other Announcement
Indrayani Biotech Limited submitted the quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Other capital structure change announcements
All →Acetech E-Commerce Capital Structure Change
Acetech E-Commerce submitted a Draft Letter of Offer for a proposed Rights Issue of equity shares up to Rs. 4000 Lakhs. The filing is a preliminary rights-issue step with issue price and ratio still blank.
- Value
- ₹40.00 Cr
Shlokka Dyes Capital Structure Change
Shlokka Dyes proposed raising its authorised capital to 2.9 crore shares, pending approval at a 28 November 2026 meeting. No fresh capital has been raised yet.
Zodiac JRD MKJ Capital Structure Change
Zodiac-JRD-MKJ received BSE in-principle approval for its Rights Issue and has convened a board meeting on 4 November 2026 to fix the issue price and record date. The issue was earlier approved for up to Rs 40 Crore.
DCW Capital Structure Change
DCW Ltd bought back 155,000 equity shares on NSE on 03-Nov-2026 at an average price of Rs.45.18. The daily report puts the day's buyback spend at about Rs.0.70 Crore.
- Value
- ₹0.70 Cr
NCL Research and Financial Services Capital Structure Change
GCM Capital Advisors and PACs disclosed selling 8,00,000 NCL Research shares, reducing holding to 5.49%. Non-promoter transaction, no consideration stated.
Shardul Securities Capital Structure Change
Shardul Securities extinguished 1,92,00,000 equity shares bought back in its October 2026 tender offer. Post-extinguishment paid-up capital falls to Rs.1,365.84 lakhs.